Posts

Showing posts with the label Benzathine Penicillin G Market Size

Benzathine Penicillin G Market Overview, Global Analysis and Forecast to 2023

Wearable Injectors Market Overview: Wearable Injectors are advanced drug delivery instruments that are used for convenient administration of viscous drugs. These instruments are also widely regarded as bolus injectors or patch pumps. They are used to administer insulin and other drugs that need large dose volumes with an extended delivery period. The Wearable Injectors Market Growth likely to ascend at a 15.2% CAGR through the review period, as stated in the latest market research report by MRFR. With an increasing prevalence of several chronic diseases and a rising concern for injuries caused by needles are promoting the demand for 24-hour monitoring devices. This rise in the demand is anticipated to propel growth in the adoption of wearable injectors to a great extent. Further, rapid technological advancements in the wearable injectors and mounting prevalence of geriatric population across the globe are likely to fuel sizeable growth in the global wearable injectors market ...

Benzathine Penicillin G Market Analysis, Growth Values and Industry Forecast to 2023

Market Highlights: Benzathine Penicillin G is an antibody used to treat various bacterial infections. It is also used in the treatment of rheumatic fever and related heart problems. The Benzathine Penicillin G Market is expected to witness tremendous growth owing to the rising prevalence of various bacterial infections such as gonorrhea, meningitis, and others. Other key factors such as a change to sedentary lifestyle, infectious diseases, respiratory infections caused due to bacterial infections, and rheumatic heart diseases contribute towards the growth of the market.  According to the World Heart Federation, 3 million people get affected with the rheumatic heart disease every year. Also, according to the Centers for Disease Control and Prevention August 2018, 370 cases of meningitis were reported in the US in 2016. Such an incidence of rheumatic heart disease and meningitis supports market growth. However, factors such as lack of awareness about the treatment and the s...